ZM-3329

N/A

Report date: 2024/07/16 11:55:03
NME

Base Information

Drug NameZM-3329
Drug Alias NameZM-3329
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN inhibitors
TargetsBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHainan Xiansheng Re Ming Pharmaceutical Co LtdState Key Laboratory of Neurology and Oncology Drug Development
China Registration ClassN/A

Develop Information

Active CompaniesState Key Laboratory of Neurology and Oncology Drug DevelopmentHainan Xiansheng Re Ming Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A